Desk›Fast Moving Consumer Goods› Nath Bio-Genes (India) Ltd
Nath Bio-Genes (India) Ltd
BSE 537291 · NSE NATHBIOGEN · ISIN INE448G01010 · Group B · Active
Fast Moving Consumer Goods › Fast Moving Consumer Goods › Agricultural Food & other Products › Other Agricultural Products
₹152.80
-0.20%
BSE close, 28 August 2026
₹290.38 cr
1.9 cr shares · Micro cap
₹157.98 cr
as published
6.1× · 0.45×
EPS ₹25.19 · BV ₹339.56
431.60 / 44.43
₹ cr, as filed
10
2 selected · 20%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -26.2% |
|---|---|
| Against 52-week low | +20.6% |
| Day change | -0.20% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹25.19 |
|---|---|
| Price / earnings | 6.07× |
| Price / book | 0.45× |
| Book value — derived, price ÷ P/B | ₹339.56 |
| Return on equity | 7.44% |
| Operating margin | 11.82% |
| Net margin | 10.12% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 7.41%
- ROE as published
- 7.44%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 322.84 | 32.66 | 17.18 | 11.82% | 10.12% |
| Mar-26 · Q | 45.69 | 3.79 | 2.17 | 22.42% | 8.29% |
| FY25-26 | 431.60 | 44.43 | 23.42 | 15.37% | 10.29% |
Quarter on quarter
- Revenue, quarter on quarter
- +606.6%
- Net profit, quarter on quarter
- +761.7%
- Operating margin, quarter on quarter
- -1,060 bps
Disclosure profile 10 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Investor Presentation | 1 |
| Results | 1 |
| Selected sub-total | 2 |
| Procedural | |
| AGM / EGM | 2 |
| Annual Report | 1 |
| Compliance Certificate | 1 |
| Corporate Action | 1 |
| General | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 8 |
| Total | 10 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
10 filings · 2 selected · busiest 2026-09-01
Filing rhythm · the twelve most recent
2026-07-232026-09-28
SelectedProcedural
Filings
10 in the window · 1 earlier on record
-
28 September 2026 ·
Closure of Trading Window
Closure of Trading window
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Proceedings of AGM and Scrutinizers report for AGM held on 24th September 2026
AGM/EGM / AGM View filing →
-
4 September 2026 ·
Corporate Action-Board to consider Dividend
Intimation for record date
Corp Action / Dividend/AGM View filing →
-
1 September 2026 ·
-
1 September 2026 ·
Reg. 34 (1) Annual Report.
Notice of Annual General Meeting and Annual Report
Others / Reg. 34 (1) Annual Report View filing →
-
1 September 2026 ·
Intimation Of Annual General Meeting
Notice of Annual General Meeting and Annual Report 2025-26
AGM/EGM / AGM View filing →
-
6 August 2026 ·
Announcement Under Reg 30 Of SEBI (LODR)
Intimation of Initiation of Forensic Audit
Company Update / General View filing →
-
30 July 2026 ·
Investor Presentation
Investor Presentation on Unaudited Financial Results as of 30th June 2026
Company Update / Investor Presentation View filing →
-
29 July 2026 ·
Financial Results As Of 30Th June 2026.
Outcome of Board Meeting: Unaudited Financial results as of 30th June 2026.
Result / Financial Results View filing →
-
23 July 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulations
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
RSS feed for Nath Bio-Genes (India) Ltd · the 50 most recent filings